Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,160 INR | +0.38% | +12.00% | +35.88% |
Sales 2024 | 118B 1.42B | Sales 2025 * | 139B 1.67B | Capitalization | 327B 3.93B |
---|---|---|---|---|---|
Net income 2024 | -15.02B -180M | Net income 2025 * | 13.26B 159M | EV / Sales 2024 | 2.29 x |
Net Debt 2024 * | 19.84B 238M | Net cash position 2025 * | 23.55B 282M | EV / Sales 2025 * | 2.19 x |
P/E ratio 2024 |
-18
x | P/E ratio 2025 * |
24.1
x | Employees | 15,556 |
Yield 2024 * |
0.2% | Yield 2025 * |
0.26% | Free-Float | 49.03% |
Latest transcript on Glenmark Pharmaceuticals Limited
1 day | +0.38% | ||
1 week | +12.00% | ||
1 month | +9.76% | ||
3 months | +25.43% | ||
6 months | +48.77% | ||
Current year | +35.88% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Chief Executive Officer | 54 | 98-10-11 | |
Ulhas Dhuppad
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-13 | |
Cherylann Pinto
BRD | Director/Board Member | 56 | 99-10-05 |
Chief Executive Officer | 54 | 98-10-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1,160 | +0.38% | 1,454,676 |
24-05-30 | 1,156 | -2.07% | 815,238 |
24-05-29 | 1,180 | +1.74% | 1,555,169 |
24-05-28 | 1,160 | +3.64% | 5,608,943 |
24-05-27 | 1,119 | +8.06% | 5,960,921 |
Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.88% | 3.92B | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-0.05% | 6.79B | |
-9.58% | 6.8B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- GLENMARK Stock